• Categories:P7仿制药
• Author:
• Origin:
• Time of issue:2021-11-20
• Views:0

(Summary description)<table class="res_table">
<thead>
<tr>
<th>Item name</th>
<th>Dosage form</th>
<th>Specifications</th>
<th>Indications</th>
</tr>
</thead>
<tbody>
<tr>
<td data-title="Name">Carbetocin</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">1ml:100μg</td>
<td data-title="Indications">It is used after selective epidural or lumbar anesthesia caesarean section to prevent uterine weakness and postpartum bleeding</td>
</tr>
<tr>
<td data-title="Name">Pitocin</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">5IU/ml，10IU/ml</td>
<td data-title="Indications">It is used for induction of labor, oxytocin, postpartum and abortion due to uterine weakness or poor contraction of uterine bleeding</td>
</tr>
<tr>
<td data-title="Name">Terisopressin acetate</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">8.5ml:1mg，1mg</td>
<td data-title="Indications">It is used for the treatment of liver cirrhosis complications (esophagogastricvariceal hemorrhage, hepatorenal syndrome, ascites) and other bleeding treatments</td>
</tr>
<tr>
<td data-title="Name">Octreotide acetate</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">1ml:0.1mg；1ml:0.2mg</td>
<td data-title="Indications">Emergency treatment of esophageal variceal hemorrhage caused by cirrhosis; Relief of symptoms and signs associated with gastrointestinal and pancreatic endocrine tumors</td>
</tr>
<tr>
<td data-title="Name">Cetrorelixacetate</td>
<td data-title="Dosage form">API + Lyophilized preparation </td>
<td data-title="Spec">0.25mg</td>
<td data-title="Indications">It is mainly used in assisted fertility technology to prevent ovulation in advance for patients with controlled ovarian stimulation.</td>
</tr>
<tr>
<td data-title="Name">Ganiric acetate</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">0.5ml:0.25mg</td>
<td data-title="Indications">It is used in women undergoing an assisted reproductive technology (ART) controlled ovarian stimulation (COS) programme</td>
</tr>
<tr>
<td data-title="Name">Atosiban acetate</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">0.9ml:735mg，5ml:37.5mg</td>
<td data-title="Indications">Gynecological fetus protection</td>
</tr>
<tr>
<td data-title="Name">Calcitriol</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">1ml:1μg</td>
<td data-title="Indications">Hypocalcemia in chronic renal dialysis patients</td>
</tr>
<tr>
<td data-title="Name">Carprostaminobuttriol</td>
<td data-title="Dosage form">API + injection</td>
<td data-title="Spec">1ml:250μg</td>
<td data-title="Indications">Suitable for pregnancy of 13 weeks to 20 weeks of abortion</td>
</tr>
</tbody>
</table>